Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KALV

KalVista

$22.62

-1.39 (-5.79%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on KalVista »

KalVista files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

09:33
12/14/18
12/14
09:33
12/14/18
09:33
Initiation
Alkermes initiated at Wolfe Research »

Alkermes initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 31

    Jan

JAZZ

Jazz Pharmaceuticals

09:32
12/14/18
12/14
09:32
12/14/18
09:32
Initiation
Jazz Pharmaceuticals initiated at Wolfe Research »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

AXON

Axovant Sciences

$1.13

-0.07 (-5.83%)

09:08
12/14/18
12/14
09:08
12/14/18
09:08
Syndicate
Axovant Sciences 30M share Spot Secondary priced at $1.00 »

Jefferies and Guggenheim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BLCM

Bellicum Pharmaceuticals

$3.60

-0.155 (-4.13%)

07:15
12/14/18
12/14
07:15
12/14/18
07:15
Hot Stocks
Bellicum Pharmaceuticals reports data from BPX-601 at ESMO-IO »

Bellicum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNMD

Conmed

$67.36

-0.07 (-0.10%)

05:11
12/14/18
12/14
05:11
12/14/18
05:11
Recommendations
Conmed analyst commentary at Piper Jaffray »

Conmed acquisition of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Thursday
CTMX

CytomX Therapeutics

$14.87

-0.13 (-0.87%)

17:04
12/13/18
12/13
17:04
12/13/18
17:04
Upgrade
CytomX Therapeutics rating change  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXON

Axovant Sciences

$1.13

-0.07 (-5.83%)

16:57
12/13/18
12/13
16:57
12/13/18
16:57
Syndicate
Axovant Sciences files to sell common stock, no amount given »

Jefferies and Guggenheim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$14.87

-0.13 (-0.87%)

16:31
12/13/18
12/13
16:31
12/13/18
16:31
Upgrade
CytomX Therapeutics rating change at Goldman Sachs »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXON

Axovant Sciences

$1.13

-0.07 (-5.83%)

16:04
12/13/18
12/13
16:04
12/13/18
16:04
Hot Stocks
Axovant Sciences licenses two gene therapies from UMass Medical School »

Axovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.